BPG is committed to discovery and dissemination of knowledge
Articles in Press
6/5/2026 8:04:55 AM | Browse: 10 | Download: 0
Publication Name World Journal of Clinical Cases
Manuscript ID 120716
DOI 10.12998/wjcc.120716
Country Greece
Category Pediatrics
Manuscript Type Case Report
Article Title De novo ARID1A Coffin-Siris syndrome, with hypothyroidism and dyslipidemia: A case report and review of literature
Manuscript Source Invited Manuscript
All Author List Michael N Fragos, Ilektra Toulia, Maria G Grammatikopoulou, Parthena Savvidou, Ioannis Taiganidis, Panagiota Zissiadis, Charalampos Antachopoulos, Dimitrios G Goulis and Kyriaki Tsiroukidou
Funding Agency and Grant Number
Corresponding Author Maria G Grammatikopoulou, Assistant Professor, PhD, Immunonutrition Unit, Department of Rheumatology and Clinical Immunology, University General Hospital of Larissa, Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis Campus, Argonafton & Filellinon Street, Larissa GR-41223, Greece. mgrammat@uth.gr
Key Words Coffin-Siris syndrome; Short stature; Hypercholesterolemia; Subclinical hypothyroidism; Dual molecular diagnosis; Diet; Neurodevelopmental disorder; Growth hormone deficiency; Lifestyle intervention; Neurodivergent; Case report
Core Tip Coffin-Siris syndrome (CSS) is a rare neurodevelopmental disorder involving the BRG1/BRM-associated factor (SWI/SNF) chromatin-remodeling complex, characterized by coarse facial features, distal phalanx hypoplasia/aplasia, developmental delay, and multisystem involvement. We report a child with CSS, subclinical hypothyroidism, and familial hypercholesterolemia caused by a heterozygous LDLR variant. Lifestyle changes and levothyroxine improved growth initially (7.6 cm/year), but later on, growth velocity declined (4.2 cm/year) in parallel to insulin-like growth factor 1 levels. A glucagon stimulation test confirmed growth hormone (GH) deficiency. Recombinant GH therapy in ARID1A-related CSS should be individualized because impaired tumor suppression and possible hepatocyte damage may increase hepatoblastoma risk.
Citation Fragos MN, Toulia I, Grammatikopoulou MG, Savvidou P, Taiganidis I, Zissiadis P, Antachopoulos C, Goulis DG, Tsiroukidou K. De novo ARID1A Coffin-Siris syndrome, with hypothyroidism and dyslipidemia: A case report and review of literature. World J Clin Cases 2026; In press
PDF 120716-in-press.pdf
Received
2026-03-06 02:15
Peer-Review Started
2026-03-06 02:15
First Decision by Editorial Office Director
2026-04-15 08:56
Return for Revision
2026-04-15 08:56
Revised
2026-05-15 18:54
Publication Fee Transferred
Second Decision by Editor
2026-06-05 03:10
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-06-05 08:04
Articles in Press
2026-06-05 08:04
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com